Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia

Hyperlipidaemia is a major risk factor for cardiovascular diseases, the leading cause of death globally. Celecoxib attenuated hypercholesterolaemia associated with CCl(4)-induced hepatic injury in rats without improving liver function in our previous study. This present study investigated the lipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekor, Martins, Owusu Agyei, Phyllis Elsie, Obese, Ernest, Biney, Robert Peter, Henneh, Isaac Tabiri, Antwi-Adjei, Meshack, Yahaya, Ewura Seidu, Amoakohene, Gordon, Akakpo, Patrick Kafui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370627/
https://www.ncbi.nlm.nih.gov/pubmed/34403420
http://dx.doi.org/10.1371/journal.pone.0247735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370627/
https://www.ncbi.nlm.nih.gov/pubmed/34403420
http://dx.doi.org/10.1371/journal.pone.0247735

Ejemplares similares